SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011752
Filing Date
2021-08-16
Accepted
2021-08-16 07:17:53
Documents
44
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plx-20210630x10q.htm   iXBRL 10-Q 968167
2 EX-31.1 plx-20210630xex31d1.htm EX-31.1 10030
3 EX-31.2 plx-20210630xex31d2.htm EX-31.2 10390
4 EX-32.1 plx-20210630xex32d1.htm EX-32.1 6090
5 EX-32.2 plx-20210630xex32d2.htm EX-32.2 6116
6 GRAPHIC plx-20210630x10q005.jpg GRAPHIC 62538
7 GRAPHIC plx-20210630x10q006.jpg GRAPHIC 66284
8 GRAPHIC plx-20210630x10q007.jpg GRAPHIC 33213
  Complete submission text file 0001558370-21-011752.txt   3636378

Data Files

Seq Description Document Type Size
9 EX-101.SCH plx-20210630.xsd EX-101.SCH 27462
10 EX-101.CAL plx-20210630_cal.xml EX-101.CAL 34415
11 EX-101.DEF plx-20210630_def.xml EX-101.DEF 86033
12 EX-101.LAB plx-20210630_lab.xml EX-101.LAB 204344
13 EX-101.PRE plx-20210630_pre.xml EX-101.PRE 174195
14 EXTRACTED XBRL INSTANCE DOCUMENT plx-20210630x10q_htm.xml XML 378391
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 211174485
SIC: 2836 Biological Products, (No Diagnostic Substances)